• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The diagnostic dilemma of hypertensive nephrosclerosis: the nephrologist's view.

作者信息

Zucchelli P, Zuccalà A

机构信息

Malpighi Department of Nephrology, Policlinico S Orsola-Malpighi, Bologna, Italy.

出版信息

Am J Kidney Dis. 1993 May;21(5 Suppl 2):87-91. doi: 10.1016/0272-6386(93)70100-d.

DOI:10.1016/0272-6386(93)70100-d
PMID:8494026
Abstract

The appearance of progressive renal disease in elderly patients with essential hypertension, sometimes irrespective of blood pressure control, is frequently related to the association of hypertension and atheromatous renal disease. This disease may lead to renal failure through a renal artery stenosis and/or chronic microembolization into the kidney. Nonsevere uncomplicated essential hypertension is constantly associated with renal vascular changes that are qualitatively indistinguishable from those related to aging. Notwithstanding the fairly constant presence of so-called benign hypertensive nephrosclerosis in patients with established hypertension, only a subset of these patients show progressive renal damage. Three mechanisms of progression may be at play: (1) a combination of ischemic and hypertensive glomerular mechanisms in some susceptible humans; (2) nonhemodynamic factors such as local immune mechanisms; or (3) the involvement of metabolic abnormalities which favor glomerulosclerosis.

摘要

相似文献

1
The diagnostic dilemma of hypertensive nephrosclerosis: the nephrologist's view.
Am J Kidney Dis. 1993 May;21(5 Suppl 2):87-91. doi: 10.1016/0272-6386(93)70100-d.
2
Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis.全身性和肾小球性高血压与慢性肾脏病的进展:肾硬化的困境
Kidney Int Suppl. 2005 Dec(99):S52-6. doi: 10.1111/j.1523-1755.2005.09910.x.
3
Hypothesis: obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled 'hypertensive nephrosclerosis'.假设:肥胖和胰岛素抵抗综合征在归因于高血压并被称为“高血压性肾硬化”的终末期肾衰竭中起主要作用。
J Hypertens. 2004 Jun;22(6):1051-5. doi: 10.1097/00004872-200406000-00001.
4
Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study.经活检证实的高血压性肾硬化患者的临床病理特征及预后:一项回顾性队列研究
BMC Nephrol. 2016 Apr 11;17:42. doi: 10.1186/s12882-016-0254-2.
5
Progression of renal failure and hypertensive nephrosclerosis.
Kidney Int Suppl. 1998 Dec;68:S55-9. doi: 10.1046/j.1523-1755.1998.06814.x.
6
Hypertensive nephrosclerosis as a relevant cause of chronic renal failure.高血压性肾硬化作为慢性肾衰竭的一个相关病因。
Hypertension. 2001 Aug;38(2):171-6. doi: 10.1161/01.hyp.38.2.171.
7
Hypertensive nephrosclerosis: pathogenesis and prevalence. Essential hypertension is an important cause of end-stage renal disease.高血压性肾硬化症:发病机制与患病率。原发性高血压是终末期肾病的重要病因。
Nephrol Dial Transplant. 1999 Oct;14(10):2271-8. doi: 10.1093/ndt/14.10.2271.
8
[Ischemic nephropathy].[缺血性肾病]
Ther Umsch. 1994 Dec;51(12):819-23.
9
The clinical diagnosis of hypertensive nephrosclerosis--how reliable is it?高血压性肾硬化的临床诊断——其可靠性如何?
Nephrol Dial Transplant. 1999 Feb;14(2):288-90. doi: 10.1093/ndt/14.2.288.
10
Renal consequences of arterial hypertension.动脉高血压的肾脏后果。
J Hypertens Suppl. 1992 Dec;10(7):S85-90.

引用本文的文献

1
A successful transfemoral transcatheter aortic valve replacement case with VIABAHN® VBX balloon-expandable stent-graft and long Dryseal sheath for challenging access route.一例使用VIABAHN® VBX球囊扩张式覆膜支架和长型Dryseal鞘管成功进行经股动脉经导管主动脉瓣置换术的病例,该病例的入路具有挑战性。
Clin Case Rep. 2023 Nov 13;11(11):e8178. doi: 10.1002/ccr3.8178. eCollection 2023 Nov.
2
Does established vascular kidney disease exist?是否存在已确诊的血管性肾病?
J Clin Hypertens (Greenwich). 2020 Feb;22(2):296-298. doi: 10.1111/jch.13818. Epub 2020 Jan 31.
3
Cholesterol-embolization syndrome: current perspectives.
胆固醇栓塞综合征:当前观点
Vasc Health Risk Manag. 2019 Jul 8;15:209-220. doi: 10.2147/VHRM.S175150. eCollection 2019.
4
Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-κB/p65 regulatory axis.循环 miR-103a-3p 通过 SNRK/NF-κB/p65 调节轴促进血管紧张素 II 诱导的肾脏炎症和纤维化。
Nat Commun. 2019 May 13;10(1):2145. doi: 10.1038/s41467-019-10116-0.
5
Atheroembolic renal disease with rapid progression and fatal outcome.动脉粥样硬化栓子性肾病,病情迅速进展,预后极差。
Clin Exp Nephrol. 2011 Feb;15(1):159-63. doi: 10.1007/s10157-010-0363-3. Epub 2010 Nov 11.
6
Renal protection and antihypertensive drugs: current status.肾脏保护与抗高血压药物:现状
Drugs. 1999 May;57(5):665-93. doi: 10.2165/00003495-199957050-00002.